Lorlatinib found to be safe and effective for patients with ALK-driven relapsed/refractory high-risk neuroblastoma
MedicalXpress Breaking News-and-Events | Apr 05, 2023
First-in-class treatment delivers major advance for incurable kidney disease
MedicalXpress Breaking News-and-Events | Apr 05, 2023
More US prostate cancer patients choosing active surveillance over surgery or radiation
MedicalXpress Breaking News-and-Events | Apr 05, 2023
ChatGPT helpful for breast cancer screening advice with certain caveats, new study finds
MedicalXpress Breaking News-and-Events | Apr 05, 2023
PANDORA test could pave the way for better oral cancer detection
MedicalXpress Breaking News-and-Events | Apr 05, 2023
Researchers develop new model for quickly evaluating potential cervical cancer drugs
MedicalXpress Breaking News-and-Events | Apr 01, 2023
Neoadjuvant chemo may benefit patients with colon cancer
MDlinx | Mar 29, 2023
Validation platform allows local hospitals to determine how well AI systems would detect breast cancer
MedicalXpress Breaking News-and-Events | Mar 22, 2023
What complementary cancer therapies are actually supported by evidence?
MDlinx | Mar 22, 2023
Researchers report method to determine the absolute dose for new radiotherapy cancer treatment technique
MedicalXpress Breaking News-and-Events | Mar 18, 2023